NCT00605033View on ClinicalTrials.gov

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Opiate DependenceDrug Dependence
Interventions
DRUG

Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484

Suboxone sublingual tablet 4 mg/1 mg - 24 mg/6 mg, daily for 28 days

DRUG

Subutex, Buprenorphine Hydrochloride, SCH 28444

Subutex sublingual tablet 4-24 mg, daily for 28 days

Sponsors

Lead Sponsor

Indivior Inc.
All Listed Sponsors
lead

Indivior Inc.

INDUSTRY

NCT00605033 - A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) | Biotech Hunter | Biotech Hunter